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Abstract. Collagen from fish is attracting a lot of attention thanks to its high absorbance ability, 
biocompatibility as well as non-religious obstruction and cheap sources. It could be applied in 
many fields, for example: food, cosmetic, or biomedicine. Using of collagen also helps reduce 
the environment pollution from fish scale waste in fish processing. In this study, collagen 
extracted from Vietnamese fresh-water tilapia fish scales was used in combination with 
carrageenan for the improvement of drug release control. The influence of fish scale collagen 
content on morphology, thermal behavior and drug release from carrageenan/collagen/ 
allopurinol composite film was evaluated by methods such as field emission scanning electron 
microscopy (FESEM), differential scanning calorimetry (DSC) and ultraviolet-visible 
spectroscopy (UV-Vis). From the DSC data, FESEM analysis and drug release of 
carrageenan/collagen/allopurinol composite films, the most suitable collagen in composite film 
is 5 wt.%.  
Keywords: fish scale collagen, drug release, carrageenan and biomedicine. 
Classification numbers: 2.7.1, 2.9.3, 2.9.4. 
1. INTRODUCTION 
Collagen is a type of protein found in animals, especially mammals. It is among the most 
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abundant fibrous proteins used in many fields due to its many advantages such as good tensile 
strength [1-2], biodegradable, non-toxic [3] and high biological compatibility [4]. It is 
considered to be one of the best biological materials to use in medicine when compared to other 
natural polymers [5]. In sources of collagen extraction, collagen from fish is currently being 
studied as a substitute for collagen extracted from terrestrial animal skins [6-8]. Collagen 
extracted from fish scales is a type I collagen. Nowadays, collagen from fish is attracting a lot of 
attention thanks to its high absorbance ability, biocompatibility, non-religious obstruction and 
cheap sources. Collagen extracted from fish scales could be applied in many fields, for example, 
food, cosmetic, or biomedicine. Use of collagen also helps reducing the environment pollution 
from fish scale waste in fish processing. In our previous studies, collagen has been successfully 
extracted from fish scale in northern Viet Nam [9].  
In recent years, bio-polymers have been increasingly studied by many researchers all over 
the world since they are abundant in nature, renewable, biocompatible and cost – effective. 
Among them, carrageenan, a water-soluble fiber, is found in many seaweeds such as red and 
brown algae. It is widely used in the food, cosmetic and pharmaceutical industries with functions 
such as gelling, thickening and stabilizing, etc. [10]. Combination of carrageenan with other 
biopolymer, for example collagen, could form a new material which has the ability to control 
drug release. Based on our previous studies, it can be reported that the poly(lactic acid)/chitosan, 
chitosan/alginate composite films containing different drugs prepared by the solution method 
have good drug release control ability [11-12]. 
Allopurinol is known as a xanthine oxidase inhibitor and a medication used to treat gout or 
kidney stones, and to decrease high blood uric acid levels. The drug half-life is 1-2 hours, and it 
has a short half-life so it is suitable for sustained release drug delivery [13]. In this paper, 
allopurinol will be used as a model drug loaded by carrageenan/collagen films.  
From the literature reviewed, the effect of collagen content extracted from fish scales on the 
characteristics of carrageenan/collagen composite films carried allopurinol drug was investigated 
and presented in this paper. Their characteristics consist of morphology, thermal properties, and 
drug release were measured and analyzed by FESEM, DSC, and UV-Vis methods.  
2. EXPERIMENTAL 
2.1. Materials  
The carrageenan used was of white powder with pH between 7.5 to 10.5 and humidity ≤                 
12 %, and the allopurinol was of white powder with purity ≥ 98 %, melting temperature ~ 300 - 
350 
o
C. Both of them were purchased from SigmaAldrich (USA). Collagen was extracted from 
tilapia scales in Northern provinces of Viet Nam with purity > 99 %. Calcium chloride (CaCl2, 
94 %), sodium hydroxide (NaOH), ethyl alcohol (ethanol, 99.7 %), methyl alcohol (methanol, 
99.7 %), and acetic acid (CH3COOH) were commercial products of China.  
2.2. Synthesis of carrageenan/collagen/allopurinol film composites 
The process of preparing carrageenan/collagen/allopurinol composites is as follows: 
Carrageenan was dissolved in distilled water at a temperature of 80 
o
C for 30 minutes, then it 
was cooled to about 40-50 
o
C and CaCl2 solution was added to the above solution. The solution 
was then stirred for 30 minutes at room temperature (denoted as solution A). Collagen and 
allopurinol were dissolved in CH3COOH 1 M solution (solution B) and NaOH 0.5 M solution 
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was prepared (solution C). Solution C was added slowly into solution A at the rate of 2 ml/min 
while the solution A was being stirred on magnetic stirrer (step 1). After that, solution B was 
added slowly into the mixture of solutions A and C at the rate of 3 ml/min while the mixture was 
being stirred on magnetic stirrer, same as step 1 (step 2). Then, the solution mixture at step 2 was 
stirred for 2 hours to stabilize. Finally, the solution mixture was poured into glass plates and 
allowed to evaporate naturally to obtain a carrageenan/collagen/allopurinol composite film. The 
weight and content of the components in the composite films are presented in Table 1.  
Table 1. Weight, content of components and the symbols of carrageenan/collagen/allopurinol composite 
films. 
No. Symbol 
Carrageenan Collagen Allopurinol 
Mass (g) 
Content 
(wt.%) 
Mass (g) 
Content 
(wt.%) 
Mass (g) 
Content 
(wt.%) 
1 CC95-5 0.095 95 0.005 5 - - 
2 ACC99-1 0.099 99 0.001 1 0.005 5 
3 ACC97-3 0.097 97 0.003 3 0.005 5 
4 ACC95-5 0.095 95 0.005 5 0.005 5 
5 ACC93-7 0.093 93 0.007 7 0.005 5 
6 ACC90-10 0.090 90 0.010 10 0.005 5 
2.3. Characterizations 
Field emissions canning electron microscope (FESEM): FESEM images of collagen and 
carrageenan/collagen/allopurinol composite films were conducted on a S-4800 instrument 
(Hitachi, Japan) at the Institute of Materials Science, Vietnam Academy of Science and 
Technology.  
Differential scanning calorimetry (DSC): DSC diagrams of carrageenan/collagen/allopurinol 
composite films were recorded on a DSC131 thermal analyzer (Setaram, France) at the 
Department of Chemistry – Hanoi University of Science. The samples were measured in the 
temperature range from room temperature to 400 
o
C with heating speed of 10 
o
C/min and in a 
nitrogen gas environment.  
2.4.  In-vitro drug release test 
Drug release of allopurinol from composite films was carried out as follows: samples (drug 
or drug-loaded by carrageenan/collagen films) were taken in vessels containing certain amount 
of release media and the drug release was assessed according to testing time. This method is 
most popular for in vitro release testing of polymers carrying drugs [14-15]. In this study, the 
certain amount of samples is 0.015 g which was put into 200 ml of buffer solution (pH 2 and pH 
7.4 solutions, corresponding to the pH in the stomach and duodenum in the human body) at                
37
 o
C ± 0.5 
o
C. The testing was carried out continuously for 32 hours with a rotation speed of 
400 rpm. After 1 testing hour, 5 ml of sample solution was drawn out and filtered through a 
hydrophilic membrance.The same volume of fresh dissolution buffer was added to replace the 
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withdrawal amount after each sampling. The amount of drug released was determined by UV-
visible spectrophotometer method. After that, the drug amount of allopurinol released from the 
composite was calculated with a standard curve prepared using bracketed concentration of 
allopurinol in each pH = 2 buffer solution and pH = 7.4  buffer solution. The standard curves of 
allopurinol in pH = 2 and pH 7.4 buffer solutions are y = 10382x + 0.051 (λmax = 257.49 nm, 
linear regression coefficient R
2
 = 0.9997) and y = 1898x + 0.0047 (λmax = 249.81 nm, R
2
 = 
0.998), respectively. All the tests were carried out at the Institute for Tropical Technology, 
Vietnam Academy of Science and Technology. 
3. RESULTS AND DISCUSSION 
3.1. Thermal properties of carrageenan/collagen/allopurinol composite films 
Figure 1 shows the DSC diagram of carrageenan/collagene/allopurinol composite films. 
The characteristics of composites films like melting temperature and melting enthalpy are 
presented in Table 2. It can be seen that all three component samples (like as ACC99-1, ACC95-
5 and ACC90-10) have endothermic peak around at around 70 
o
C. This endothermic peak 
corresponds to the modified temperature of collagen. This result is consistent with the result of 
determining pure collagen (73.0 
o
C). However, this endothermic peak does not appear in the 
CC95-5 composite film (without allopurinol). This may be due to collagen having good 
interaction with carrageenan. From the Table 2, the ACC99-1 sample (containing 1wt.% of 
collagen) has the highest modified temperature (73.5 
o
C), and the modified temperature of this 
sample gradually goes down to 61.2 
o
C when increasing the collagen content to 5 wt.%. This 
value of composite film containing 10 wt.% of collagen (ACC90-10 sample) is 66.4 
o
C. Among 
investigated samples, the composite film containing 5 wt.% of collagen (ACC95-5 sample) has 
lowest modified temperature. It suggests that collagen has strongly interacted with carrageenan 
at 5 wt.% of collagen.  
 
Figure 1. DSC diagram of composite films (CC95-5 (1), ACC99-1 (2), ACC95-5 (3) and ACC90-10 (4)). 
The Figure 1 also indicates that all of samples have 2 other peaks, which are endothermic 
peak and exothermic peaks at around 150 
o
C and 250 
o
C, respectively. The endothermic peak 
and exothermic of composite films are correspondingly representing for the melting and 
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decomposing temperature of collagen and carrageenan. For examples, the melting and 
decomposing temperature of CC95-5 sample are 131.3 
o
C and 226.9 
o
C, respectively. The 
melting temperature of composite film is fluctuated along with the change of collagen contents. 
It is 151.4, 157.9 and 153.6 
o
C for the composite film containing 1 wt.%, 5 wt.% and 10 wt.% of 
collagen, respectively.  
Another issue is that the temperature of composite films containing allopurinol (ACC 
samples) being larger than that of the composite film without allopurinol (CC95-5 sample). This 
is explained by the melting temperature of allopurinol being higher than that of collagen and 
carrageenan, so the melting temperature of the composite film is increased when mixing 
allopurinol with collagen and carrageenan. This also indicates that these components of 
composite films can be interacted well together. Besides, the increase in melting temperature 
leads to rising up of melting enthalpy (Table 2). It is clear that the CC95-5 composite film has 
smallest melting temperature and melting enthalpy is of 464.58 J/g. By contrary, the melting 
enthalpies of the drug carrying composite films (ACC samples) is higher than that of CC95-5. 
Among the drug carrying composite films, the composite film containing 5 wt. % of collagen 
(ACC95-5) has smallest value of melting enthalpy (599.82 J/g). Thus, the ACC95-5 composite 
film has the lowest crystallinity due to the melting enthalpy is proportional to crystallinity. The 
degradation temperature of composite films containing allopurinol tends to rise up compared 
with that of the composite film without allopurinol, for example, the CC95-5 sample has the 
lowest degradation temperature (226.9 
o
C) while the ACC991-1, ACC95-5 and ACC90-10 
samples have degradation temperature at around 250 
o
C (Figure 1b). The degradation enthalpy 
of composite films is higher than that of composite film without allopurinol, for example, the 
CC95-5 and  the ACC95-5 composite films has highest value (-45.07 J/g).  
 
Table 2. DSC data of carrageenan/collagen/allopurinol composite films, Tm: melting temperature,                      
Tdm: maximum degradation temperature, Hm: melting enthalpy, Hd: degradation enthalpy. 
Samples Tm1 (
o
C) Tm2 (
o
C) Tdm (
o
C) Hm (J/g) Hd (J/g) 
CC95-5 - 131.3 226.9 464.58 -156.15 
ACC99-1 73.5 151.4 248.3 760.51 -82.87 
ACC95-5 61.2 157.9 254.1 599.82 -45.07 
ACC90-10 66.4 153.7 252.3 858.82 -90.65 
From the above results, it can be seen that the composite film containing 5 % of collagen 
has lowest crystallinity degree. This may increase the ability to release allopurinol drug from 
carrageenan/collagen/allopurinol composites films.  
3.2. Morphology 
FESEM images of carrageenan/collagen and carrageenan/collagen/allopurinol composites 
at the same magnification are presented in Figure 2.  
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Figure 2. FESEM image of carrageenan/collagen/allopurinol composite films with:  
(a) CC95-5, (b) ACC99-1, (c) ACC95-5 and (d) ACC90-10. 
It can be easily seen that the carrageenan/collagen composites (CC95-5) composite film has 
a relatively homogeneous structure due to good interaction between the carrageenan and 
collagen (Figure 2a). When the allopurinol is added into the carrageenan/collagen blends, the 
structure of composite films becomes separated two-phase structure with dispersed phase 
(allopurinol)  in polymers (carrageenan and collagen) (Figures 2b, c and d). From Figure 2c, the 
composite containing 5 wt.% of collagen (ACC95-5) has a more uniform structure compared 
with others composites with the different collagen content because the separation of phases is 
not clear in this samples and difficult to observe. Therefore, the dispersion of allopurinol into 
polymers is best at 5 wt.% of collagen and this is consistent with the above results. 
3.3. Drug release 
The drug content of allopurinol released from composite films (ACC99-1, ACC97-3, 
ACC95-5, ACC93-7, ACC90-10) in buffer solutions is displayed in Figure 3. It can be seen that, the 
release of allopurinol from composite films occured in two stages: (1) the rapid release process 
took place for first testing 11 hours, and (2) then, the slow one indicated the controlled release of 
drugs at the end of period (the next testing 17 hours). 
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Figure 3. In vitro drug release of allopurinol from carrageenan/collagen/allopurinol composite films                           
in pH = 2 and pH = 7.4 buffer solutions. 
Figure 3 also demonstrates that the ratio of carrageenan and collagen significantly affected 
the release of allopurinol from carrageenan/collagen/allopurinol composite films in buffer 
solution pH = 2. The content of allopurinol released from ACC955-5 (carrageenan/collagen/ 
allopurinol ratio of 95/5/5, wt.%) is the smallest in all samples at the rapid release stage (period 
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1), but it is highest (42.06 %) at the period 2 (the controlled release stage) after testing 28 hours. 
This may be due to the fact that the interaction between collagen and carrageenan in this ratio is 
stronger than that of composite films with other ratios of collagen and carrageenan, so the 
crystallinity of ACC95-5 is reduced as mentioned above. The amount of allopurinol released 
from the ACC95-5 composite film is more than that from other samples during allopurinol 
released testing in buffer solution pH = 2. 
In the buffer solution pH = 7.4, among the investigated composite films, the ACC95-5 
composite film has the highest amount of allopurinol released. For example, the allopurinol 
amount released for testing 12 hours and testing 28 hours are 53.96 and 57.39 %, respectively. 
The drug release content from ACC99-1, ACC97-3, ACC95-5, ACC93-7, ACC90-10 composite 
films in pH = 7.4 solution are 52.23 %, 53.43 %, 57.39 %, 52.29 % and 53.60 % after testing 28 
hours, respectively. This indicates that the most suitable content of collagen for best released 
drug is 5 % which corresponding to the sample having a 95:5 ratio of carrageenan and collagen 
(ACC95-5). The allopurinol amount released from the composite film in buffer solution pH = 
7.4 is significantly higher than that released in buffer solution pH = 2. The rapid release of 
allopurinol is occurred may be due to the drug on the surface of compositefilm being released. 
On the other hand, the interactions between collagen and carrageenan are hydrogen bonding and 
bipolar interaction, so the diffusion ability of allopurinol into solution is increased. 
4. CONCLUSSION 
In this work, the carrageenan/collagen composite films containing allopurinol is prepared 
by solution method. The results of DSC analysis indicate that the composite film containing 5 % 
of collagen (ACC95-5) has the highest melting temperature and the smallest melting enthalpy. 
This proves that the ACC95-5 composite film is the most durable. FESEM images show that the 
carrageenan/collagen composites (CC95-5) composite film has homogeneous structure while the 
carrageenan/collagen/allopurinol composite films have structure with two separate phases (a 
matrix phase and dispersed phase). The composite film containing 5 % of collagen (ACC95-5) 
has a more uniform structure compared with other composites having different collagen content. 
The result of released drug indicates that the ratio of carrageenan and collagen significantly 
influences on the release of allopurinol from carrageenan/collagen/allopurinol composite films. 
The content of allopurinol released from ACC955-5 composite film is highest (42.06 %) in both 
buffer solutions (pH 2 and 7.4). The release ability of allopurinol in buffer solutions is arranged 
in the following order: pH 7.4 > pH 2. 
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